Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views? — Neutral
CVS Zacks Investment Research — August 04, 2025The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Idexx (IDXX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates — Positive
IDXX Zacks Investment Research — August 04, 2025Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Is GE (GE) a Buy as Wall Street Analysts Look Optimistic? — Positive
GE Zacks Investment Research — August 04, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Compared to Estimates, Northern Oil and Gas (NOG) Q2 Earnings: A Look at Key Metrics — Positive
NOG Zacks Investment Research — August 04, 2025The headline numbers for Northern Oil and Gas (NOG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Should You Invest in StoneCo (STNE) Based on Bullish Wall Street Views? — Positive
STNE Zacks Investment Research — August 04, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
BRKR Zacks Investment Research — August 04, 2025The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Is It Worth Investing in Toll Brothers (TOL) Based on Wall Street's Bullish Views? — Positive
TOL Zacks Investment Research — August 04, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Energizer (ENR) Reports Q3 Earnings: What Key Metrics Have to Say — Positive
ENR Zacks Investment Research — August 04, 2025The headline numbers for Energizer (ENR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Is It Worth Investing in Progressive (PGR) Based on Wall Street's Bullish Views? — Positive
PGR Zacks Investment Research — August 04, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Here's What Key Metrics Tell Us About Axsome (AXSM) Q2 Earnings — Neutral
AXSM Zacks Investment Research — August 04, 2025While the top- and bottom-line numbers for Axsome (AXSM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Wall Street Analysts Think OneSpan (OSPN) Is a Good Investment: Is It? — Positive
OSPN Zacks Investment Research — August 04, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Bulls Look Optimistic About Newmont (NEM): Should You Buy? — Positive
NEM Zacks Investment Research — August 04, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Compared to Estimates, Wayfair (W) Q2 Earnings: A Look at Key Metrics — Positive
W Zacks Investment Research — August 04, 2025The headline numbers for Wayfair (W) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

IAK: Insurers Offer Attractive Returns After Recent Underperformance — Negative
IAK Seeking Alpha — August 04, 2025The iShares U.S. Insurance ETF allocates its assets primarily to Property & Casualty insurance stocks. Southern California wildfires have likely contributed to IAK underperforming U.S. financials so far this year, in line with trends observed during past natural disasters. Weak price gains have resulted in IAK holdings trading at only 12x their trailing earnings, a 33% discount to U.S. financials ex-insurance.

Jim Cramer breaks down why he's keeping an eye on shares of Wayfair.

TORONTO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE: MUX) (TSX: MUX) (“McEwen”, "MUX" or the "Company”) invites you to join our conference call following the release of our Q2 2025 financial results. The call will take place on Thursday, August 7, 2025 at 11:00 AM EDT. Management will discuss our financial results and project developments and follow with a question-and-answer session. Participants can ask questions directly over the phone during the webcast.

Performant Healthcare (PHLT) Surges 115.2%: Is This an Indication of Further Gains? — Positive
PHLT Zacks Investment Research — August 04, 2025Performant Healthcare (PHLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Jim Cramer breaks down why he's keeping an eye on shares of Disney.

Twilio Q2 Preview: Focusing On Net Retention And Cross-Selling, Initiate With Buy — Positive
TWLO Seeking Alpha — August 04, 2025Initiate Twilio with a buy rating and $154 fair value, based on AI-driven customer engagement and margin expansion focus. Growth slowed post-pandemic due to market saturation, a lower net expansion rate, and intensifying competition, but margin and FCF improvements are notable. New CEO's cost discipline improved FCF margin and enabled significant share repurchases, supporting higher valuation.

Diageo guidance for 2026 likely to be flat or lower, cautions analyst — Negative
DEO Proactive Investors — August 04, 2025Diageo PLC (LSE:DGE) should be able to 'split the G' and hit guidance this year, according to analysts at Citi, but the main investor focus will be on the outlook when full-year results are released on 5 August. The US bank, which reiterated its 'buy' rating on the share, expects organic sales growth (OSG) guidance for the year to June 2026 to be "subdued", potentially "flat-to-slightly lower" than the past year.
